Registry for Advanced Endoscopy

NCT05187312 — Recruiting, 1000 participants, Region Stockholm
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Research Registry for Endoscopic Treatment and Diagnostics

RegistryNCT05187312, acronym ERDB
StatusRecruiting
Study typeObservational
Enrollment1000 (Estimated)
SponsorRegion Stockholm (Other gov); collaborators: Karolinska Institutet
ConditionsCholangiocarcinoma, Pancreatic Cancer, Sclerosing Cholangitis
InterventionsEndoscopic retrograde Cholangio- pancreatography, Endoscopic ultrasound (Procedure)
Datesstart 2022-01-14, primary completion 2032-01-14 (estimated), completion 2032-01-14 (estimated), first posted 2022-01-11, last updated 2024-04-12
Locations1 site in Sweden

Related Papers Related Patents Related Grants Related Experts
All trials for Cholangiocarcinoma All trials for Pancreatic Cancer All trials of Endoscopic retrograde Cholangio- pancreatography All trials of Endoscopic ultrasound

-Summary

Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract

Expand all sections  ·  Collapse all

+Arms and interventions

  • Endoscopic retrograde Cholangio- pancreatography (Procedure): Endoscopic intervention in the biliary or pancreatic duct
  • Endoscopic ultrasound (Procedure): Endoscopic investigation/intervention with ultrasound

+Outcome measures

Primary outcomes

  • Adverse events [30-days and 60-days post-procedure]: Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event
  • Diagnostic yield [1-year follow up]: Diagnostic yield after tissue sampling

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Clinical indication for endoscopic intervention/procedure

Exclusion Criteria:

* No informed consent
* Age <18 years

+Locations (1)

FacilityCityCountryStatus
Karolinska University HospitalStockholmSwedenRecruiting

+Investigators